ChIP coupled with microarray provides a powerful tool to determine in vivo binding profiling of transcription factors to deduce regulatory circuitries in mammalian cells. Aiming at improving the specificity and sensitivity of such analysis, we developed a new technology called ChIP-DSL using the DNA selection and ligation (DSL) strategy, permitting robust analysis with much reduced materials compared with standard procedures. We profiled general and sequence-specific DNA binding transcription factors using a full human genome promoter array based on the ChIP-DSL technology, revealing an unprecedented number of the estrogen receptor (ER␣) target genes in MCF-7 cells. Coupled with gene expression profiling, we found that only a fraction of these direct ER␣ target genes were highly responsive to estrogen and that the expression of those ER␣-bound, estrogen-inducible genes was associated with breast cancer progression in humans. This study demonstrates the power of the ChIP-DSL technology in revealing regulatory gene expression programs that have been previously invisible in the human genome.
T
he elucidation of genomes for humans and other model organisms has made it possible to conduct analysis of gene expression and regulation at the genome scale. Gene expression is generally accompanied by chromatin remodeling activities and histone modifications. An important conceptual advance has been the ''histone code'' hypothesis, which suggests that histone modifications reflect a sequential action of enzymes associated with the transcriptional machinery such that one prior activity may influence the next during regulated gene expression (1, 2) . Histone acetylation results in charge neutralization of modified lysines, which is generally associated with gene activation (3) . In contrast, histone methylation on different residues appears to provide binding sites for specific transcription regulators, thereby positively or negatively affecting gene expression (4) . Although histone methylation may modulate gene expression in a gene-specific and context-dependent manner, certain site-specific modifications appear to be generally applicable to most genes. The epigenetic markers thus provide a roadmap to identify and characterize functional DNA elements in the genome.
The nuclear receptor (NR) superfamily of transcriptional regulators plays a central role in many developmental and disease processes, and the system has been extensively studied as a model to learn the mechanism for spatial and temporal control of gene expression (5) . Individual NRs have consensus binding sites in promoters and enhancers, which have been characterized in detail, but only in a limited number of NR-regulated genes. In the case of the pS2 gene (also known as TFF1), for example, binding by estrogen receptor ␣ (ER␣) initiates sequential recruitment of a large number of transcription factors onto the promoter to start transcription (6) . However, despite extensive mechanistic insights in transcriptional initiation in this and other well studied cases, little is known about how many genes are direct targets for an NR. Genome-wide ChIP coupled with microarray, known as ChIP-onchip, offers a solution to this problem by determining promoters bound directly by transcription factors (7) (8) (9) (10) . Surprisingly, however, recent promoter and tiling array analyses suggest that ER␣ binds relatively rarely to gene promoters compared with intergenic regions, suggesting a critical role of long-distance enhancers in regulated gene expression in mammalian cells (11) (12) (13) .
Here we describe an approach to detecting in vivo DNA-protein interactions by coupling ChIP with a DNA selection and ligation (DSL) strategy, permitting analysis of many fewer cells than required by the conventional ChIP-on-chip method. We constructed a full genome promoter array based on this ChIP-DSL platform, and our analysis revealed that ER␣ bound to Ͼ3% of human genes in promoter-proximal regions in MCF-7 cells, reinforcing the importance of direct binding events in the promoter-proximal regions during regulated gene expression. Results from built-in tiling arrays allowed direct visualization of binding events even without statistical filtering of raw data, and a comprehensive histone modification profile extended the current histone code hypothesis. These results demonstrate the versatility and accuracy of the ChIP-DSL technology in a genome-wide search for direct target genes by specific transcription factors and in comprehensive analysis of regulatory programs within specific genomic loci. Furthermore, comparison between profiles of ER␣ binding and 17␤-estradiol (E 2 )-induced gene expression in MCF-7 cells revealed a subset of genes whose expression tracks breast cancer progression in humans, which not only suggests the prognostic value of these genes as biomarkers for breast cancer but also illustrates a general strategy for dissecting molecular pathways in cancer. 
Results and Discussion
Design and Development of the ChIP-DSL Technology. Aiming to detect functional DNA elements with high sensitivity and specificity, we devised a multiplex assay by coupling ChIP with a DSL approach (Fig. 1) . A signature 40-nt sequence is first computationally identified in a genomic segment 0.5-1 kb in length. For promoter profiling each such probe corresponds to a proximal promoter region from ϩ200 nt to Ϫ800 nt relative to the transcription start, which contains Ϸ95% of known binding sites for transcription factors in humans (8) . To construct a tiling array, each probe is used to represent an Ϸ0.5-kb nonrepetitive genomic block in a path to be tiled. This probe density takes into account the number of probes required for maximal coverage of genomic sequences and the sufficiency in detecting immunoprecipitated DNA, which is generally sheared to an average length of 0.5-1 kb. Amine-modified 40-mers are spotted onto solid support to form an array.
Corresponding to each 40-mer, a pair of assay oligonucleotides are synthesized, each consisting of the two 20-mer halves in the 40-mer and flanked by a universal primer landing site. Multiple oligonucleotide pairs are mixed to form a pool. The assay begins with standard ChIP, and the isolated DNA is randomly biotinylated followed by annealing to the oligonucleotide pool. Annealed oligonucleotides are selected on streptavidin-conjugated magnetic beads, and unannealed oligonucleotides are washed away. This selection strategy allows the use of an excessive amount of oligonucleotides to achieve maximal annealing that follows the pseudofirst-order kinetics and prevents interference of later steps by excess free oligonucleotides in solution. All selected oligonucleotides are immobilized, and those paired by specific target DNA are ligated, thereby converting only correctly targeted oligonucleotides to full amplicons for PCR amplification. One of the PCR primers is end-labeled with a fluorescent dye so that the PCR products can be directly hybridized to the 40-mer array.
This technology is distinct from the conventional ChIP-on-chip assay in several key aspects. First, chromatin immunoprecipitated DNA was used to template oligonucleotide ligation, instead of being directly amplified for hybridization. This step can tolerate incomplete decross-linking because cross-linking adducts should have less effect on oligonucleotide hybridization than signal amplification by a polymerase. Second, we targeted only unique signature sequences in the human genome, thereby avoiding potential interference of repetitive and related sequences during hybridization. Third, the sensitivity is significantly elevated by PCR amplification of ligated oligonucleotides in an unbiased fashion because all amplicons contain the same pair of specific primer landing sites and are uniform in length as previously documented (14) .
We progressively enlarged the multiplicity of the assay to eventually cover most annotated gene promoters in the human genome. Titration experiments indicate that the ChIP-DSL technology could routinely operate with cells from one-third of a single 100-mm culture dish, which corresponds to 1-5 ϫ 10 6 cells, depending on the cell type under investigation. Despite the fact that each promoter is targeted by one oligonucleotide pair, high-quality data generated as reported in this and other studies (15) demonstrate the reproducibility and robustness of the ChIP-DSL technology.
We initially assessed promoters potentially active in transcription based on their association with RNA polymerase (Pol) II in E 2 -treated MCF-7 cells (Fig. 2A) . Anti-Pol II-enriched (Pol II ϩ ) promoters (red) were clearly segregated from background marked by built-in tiling array controls (yellow), finding that 43% of total promoters were Pol II ϩ at a standard P value Ͻ 0.001. Quantitative ChIP/quantitative PCR (qPCR) analysis of randomly selected promoters suggests a false positive rate of Ϸ3% and a false negative rate of Ϸ33% [ Fig. 2B and supporting information (SI) Fig. 6 ]. A similar false positive rate was observed by using an irrelevant IgG (SI Fig. 7A ). The false negative rate is quite similar to that reported in published ChIP-chip studies (16) . Pol II ϩ promoters were also marked by AcH3K9 (98%), Me 2 H3K4 (98%), and Me 3 H3K4 (88%), although a significant fraction of promoters were associated only with these gene activation marks, but not with Pol II (Fig. 2C) . In contrast, the ''repressive'' histone mark Me 3 H3K27 was detected in only a small fraction (10%) of Pol II ϩ promoters. Indeed, this repressive histone mark has been shown to associate with some active genes (17) . An RNA profiling experiment in the same E 2 -stimulated MCF-7 cells showed that most Pol II ϩ promoters were actively transcribing (Fig. 2D) . Collectively, these robust and highly consistent data testify to the utility and sensitivity of the ChIP-DSL technology.
Identification of ER␣-Occupied Gene Promoters in the Human Genome. We next applied the ChIP-DSL technology to identify target genes for sequence-specific DNA-binding transcription factors. ER␣ plays an important role in human reproduction and breast cancer. Recent promoter profiling analysis using 1-kb promoter regions detected 153 ER␣-bound promoters (13) . Further, tiling analysis of ER␣ binding suggests that ER␣ binds prevalently to intergenic regions in the human genome, suggesting a new paradigm that estrogen-regulated gene expression may be largely driven by long-distance enhancers (11, 12) . Complimentary to these recent genomic analyses, we scored Ϸ1,300 anti-ER␣-enriched (ER␣ ϩ ) promoters in E 2 -stimulated MCF-7 cells based on the single-array error model (9) at the standard cutoff of P Ͻ 0.001, and Ϸ700 at a more stringent cutoff of P Ͻ 0.0001 (Fig. 3A) . A significant number of ER␣ ϩ promoters were also identified in vehicle-treated MCF-7 cells, suggesting a class of hormone-independent recruitment events (SI Fig. 7B ). To identify ER␣ ϩ promoters with high statistical confidence, we analyzed the data from multiple biological repeats using three statistical methods that are based on distinct mathematical principles, revealing an overlapping set of 578 highest confidence ER␣ ϩ promoters, which represents 3.3% of all reliably scored promoters ( Fig. 3B and SI Data Set 1).
ChIP/qPCR analysis confirmed all ER␣ ϩ promoters examined, including those residing in chromosomes 21 and 22 ( Fig. 3C ) and 20 additional promoters in other chromosomes (data not shown), indicating a negligible false positive rate for anti-ER␣ ϩ -enriched promoters supported by stringent statistical tests. Estimation of the false negative rate proved to be challenging when the majority of the probes are in the ''negative'' population (8) . We used ChIP/qPCRconfirmed promoters recently reported (13) to objectively estimate our false negative rate. Among 27 validated promoters common between the two array platforms, 20 were scored positive in our array at P Ͻ 0.0001 and 24 at P Ͻ 0.001, indicating that our false negative rate is Ϸ26% and 11% at the two P value cutoffs, respectively, which is probably an overestimate, because three promoters (CYP4F3, PROP1, and ABCG2) not detected were enriched only Ͻ2-fold in previous ChIP/qPCR experiments (13).
Together, these results demonstrate the accuracy of the ChIP-DSL data and conservatively identify Ϸ4-fold as many ER␣ target promoters as were detected in previous genome-wide location analysis, suggesting that the promoter array based on the ChIP-DSL technology is a useful resource for the general research community.
We next conducted motif analysis using a newly refined algorithm, which compares ChIP-enriched promoters against normalized nucleotide frequencies in all promoters (C.B. and C.K.G., unpublished data), revealing a highly enriched, but uncharacterized, motif associated with ER␣-bound promoters (Fig. 3D ). When this motif was masked, the next most enriched motifs were the classic ER␣-binding consensus sequences (18) , which are present in 44% of the total ER␣ ϩ promoters (Fig. 3D) . Interestingly, whereas the algorithm confirmed the presence of FoxA1 recognition motifs surrounding a fraction of intergenic ER␣ binding sites (11), it did not detect extensive association of the FoxA1 binding site with the 
ER␣
ϩ promoters identified by ChIP-DSL. In light of the finding that FoxA1 is critical for ER␣ binding to several target genes examined (11, 13) , it will be interesting to determine in future studies whether FoxA1 is selectively or universally required for ER␣ targeting.
Locus-Specific Tiling Array Analysis of ER␣ Binding and Histone
Modifications. To facilitate data analysis of promoter arrays, we built in a number of tiled loci to serve as internal negative controls because not all genomic regions are expected to be occupied by general and sequence-specific DNA binding transcription factors. The data in turn illustrate the usefulness of the ChIP-DSL technology in revealing specific molecular recognition events that constitute the regulatory programs in individual genomic loci. As illustrated in Fig. 4 , we found that ER␣ bound to the promoter (filled arrow) and a putative enhancer (open arrow) of the TFF1 gene, as previously reported (11) . The transcriptional coactivator CBP similarly interacted with both promoter and enhancer, whereas Pol II covered the body of this relatively small gene. In the case of the GREB1 gene, we observed a similar pattern with ER␣, CBP, and Pol II present on two of the three promoters that were previously characterized (19) . Interestingly, we found that all three factors interacted with three distinct loci upstream of the GREB1 promoters, suggesting that these sites may function as enhancers. These observations are consistent with a large body of literature that gene promoters and enhancers are recognized by sequencespecific DNA-binding transcription factors, which in turn recruit transcription coactivators.
Acetylated histone (AcH3K9) was observed in both promoters and enhancers in TFF1 and GREB1 as expected. Histone 3 lysine-4 methylation is generally associated with active genes, but the profile of individual modifications is significantly distinct: Me 1 H3K4 seems to associate broadly with active genes, but, in contrast to the situation in yeast, this modification is not preferentially linked to the 3Ј end of active genes (2, 20, 21) . Me 2 H3K4 marks both promoters and enhancers with a clear preference for promoters over enhancers. Again, in contrast to events in yeast, we did not detect substantial Me 2 H3K4 in the transcribed regions of GREB1 and other tiled genes. Me 3 H3K4 was found exclusively in promoters, which agrees with most mapping studies in yeast and mammalian cells (20, 22, 23) .
Interestingly, AcH3K9 and methylated H3K4 marks were present in a number of gene promoters, including KAI1 (Fig. 4) , where no RNA transcripts were detected in MCF-7 cells. These observations suggest either that some histone modifications take place before the recruitment of the general transcriptional machinery or that these genes may be transcribing at an undetectable basal level. Although one cannot formally distinguish between these possibilities, the histone modification pattern is clearly different from ''silent'' genes such as RAR␤ (Fig. 4) . The RAR␤ promoter was specifically marked by Me 3 H3K27, which is generally associated with silent genes in heterochromatin (24) . Thus, there is heterogeneity in marks of nonexpressed genes exemplified by the observation that the KAI1 promoter is accessible to transcription factors, whereas the RAR␤ promoter is actively repressed in MCF-7 cells.
To further characterize histone modifications associated with gene repression, we mapped Me 2 H3K79 and Me 3 H3K9 (Fig. 4) . Me 2 H3K79 has been previously implicated in interactions with Sir proteins during gene silencing (25, 26) , although a more recent study suggested a link of this modification to gene activation (27) . We found that Me 2 H3K79 was indeed associated with active genes, but in a distinct, gene-specific manner. In the case of TFF1, this modification took place in the transcribing region near the promoter, whereas in the case of GREB1, Me 2 H3K79 was spread in the entire transcription unit, including both coding and promoter/ enhancer regions. Me 3 H3K9 has also been previously linked to gene repression by serving as the binding site for HP1 to facilitate the assembly of heterochromatin (25, 26, (28) (29) (30) . Here we found that Me 3 H3K9 decorated most 3Ј transcribed regions of both TFF1 and GREB1, consistent with a role of this specific histone modification in transcription elongation as recently suggested in yeast (31) . These findings illustrate that it is still quite precipitous to generalize the significance of most histone modification events with respect to gene activation or repression, as the same histone modification may reflect or influence transcription positively or negatively in a highly gene-specific and locus-dependent manner, consistent with a combinatorial histone code.
Expression of Direct ER␣ Target Genes in Breast Cancer Cells and
Tissues. While the majority of ⌭R␣-bound promoters were also marked by Pol II and epigenetic markers associated with gene activation (Fig. 5A) , we evaluated the time course of regulated gene expression by RNA profiling and identified 879 genes that responded to E 2 -induction in MCF-7 cells, which generally agrees with other published gene expression profiling studies (32) (33) (34) . Strikingly, only 54 of these 879 E 2 -affected genes were bound by ER␣ in the promoter-proximal region (Fig. 5B) , indicating that the majority of E 2 -induced genes might be indirectly affected or regulated by ER-responsive elements located away from the promoterproximal region. Among these 879 E 2 -regulated genes, 562 were up-regulated and 317 were down-regulated. Contrary to the expectation that a similar percentage of genes in these two categories would be targeted by ER␣ in the promoter-proximal region, we found that 49 (10.5%) of ER␣-bound promoters were up-regulated by E 2 , whereas only 5 (1.1%) were down-regulated (Fig. 5 B and C) . These observations suggest that many genes in both up-and down-regulated categories might be indirectly affected, with more down-regulated genes influenced by indirect mechanisms than up-regulated ones (35) .
Conversely, the fact that only 54 ER␣-bound promoters responded to E 2 with rapid changes in mRNA levels suggests that most ER␣-bound promoters may require additional cofactors for E 2 -dependent gene expression, as has been previously documented (36) (37) (38) (39) . Consequently, we predicted that different sets of ER␣-occupied promoters might respond to E 2 stimulation in different cell types. Indeed, we have found that a subset of ER␣-bound, but E 2 -insensitive, promoters in MCF-7 cells could be directly targeted by ER␣ and induced by E 2 in U2OS cells stably expressing ER␣ (data not shown). This observation suggests that, at least for some promoters, they represent bona fide estrogen target genes under different circumstances.
To further investigate the biological relevance of ER␣-binding and estrogen-regulated gene expression, we asked how the newly identified 54 E 2 -responsive ER␣ target genes might be differentially regulated in breast cancer tissues using a comprehensive set of gene expression profiling data from 251 breast cancer patients (40) . We found a direct correlation between gene expression and tumor progression by unsupervised hierarchical clustering (Fig. 5D ). Patients were clustered into three groups. About half of the genes were strongly suppressed in group 2, which displayed an ER-negative status and advanced tumor grade (Fig. 5D) . Significantly, this Gene expression profiling in response to E2 treatment. ER␣-bound and E 2-regulated genes are grouped into four distinct classes. Among up-regulated genes, 29 were rapidly induced, and the level remained relatively constant afterward; eight were induced in a time-dependent manner; and 12 were induced followed by a rapid decay. E 2-induced, genes represent 10.5% of total ER␣-bound genes in the promoter-proximal region. Only five ER␣-bound genes were down-regulated by E2, which represent 1.1% of total ER␣-bound genes in the promoter-proximal region. (D) Segregation of ER expression and breast tumor grade (both indicated at the top by blue bars) based on ER␣-bound and E 2-induced genes in MCF-7 cells. (E) Kaplan-Meier plots of patient survival in different groups segregated based on ER␣-bound and E2-inducted genes in MCF-7 cells. Statistical significance was determined by the 2 test.
